Clinical Trial Update: Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing anastrozole alone versus maximal estrogen blockade with anastrozole plus fulvestrant in breast cancer has completed and posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ARIMIDEX (anastrozole)
• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-02-09